Shanti Inorganics Limited
SMESHANTIINOR • BSE, NSE
Issue details
Price band
₹79 - ₹83
Lot size
1,600 shares
Issue size
₹33.8 Cr
Min. investment
₹1,32,800
Registrar
KFin Technologies
Subscription
132.30x · 91,786 applications
Grey market premium
Est. gain+₹54 · 65%
Save your family's PANs once and check allotment for everyone the moment results are out.
Sign in with a mobile OTP. It takes 20 seconds.
IPO Timeline
Open
31 Aug
Close
2 Sep
Allotment
3 Sep
Listing
7 Sep
- Refunds & demat credit
- 4 Sep 2026
- Mandate end
- 17 Sep 2026
We calculate these dates from the allotment and close dates, so please treat them as indicative.
Application size
| Category | Minimum | Maximum |
|---|---|---|
| Retail | 1,600shares 1 lot · ₹1,32,800 | 1,600shares 1 lot · ₹1,32,800 |
| HNI | 3,200shares 2 lots · ₹2,65,600 | No limit funds permitting |
Based on the upper price band of ₹83 and a lot of 1,600 shares.
Subscription
| Quota | Shares offered | Shares bid | Applications | Subscribed |
|---|---|---|---|---|
| Total | 40,72,000 | 53,87,15,200 | 91,786 | 132.30x |
Last updated 7 days ago.
Issue structure
Face value
₹10 per share
Issue type
Bookbuilding IPO
Sale type
Fresh capital only
Fresh issue
₹45 Cr
54,06,400 shares
Shares pre-issue
1,15,56,200
Shares post-issue
1,72,47,400
Valuation & ratios
| Metric | Pre-IPO | Post-IPO |
|---|---|---|
| EPS | 8.84 | 8.7 |
| P/E | 9.39 | 9.54 |
| Market cap | ₹96Cr. | ₹143.15 Cr |
| KPI | May 31, 2026 | Mar 31, 2026 |
|---|---|---|
| ROE | 5.05% | 27.68% |
| ROCE | 4.45% | 23.40% |
| Debt/Equity | 0.69 | 0.64 |
| RoNW | 5.05% | 27.68% |
| PAT Margin | 15.53% | 14.01% |
| EBITDA Margin | 25.16% | 21.62% |
| NAV | 43.91 | 41.74 |
| Price to Book Value | 1.89 | 1.99 |
Financials
| Metric | 31 May 2026 | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|---|
| Total income | 16.1 | 72.93 | 58.46 | 45.06 |
| Profit after tax | 2.5 | 10.22 | 7.99 | 5.12 |
| EBITDA | 4.02 | 15.4 | 12.06 | 8.72 |
| Net worth | 50.74 | 48.24 | 25.6 | 17.6 |
| Assets | 110.73 | 97.04 | 66.04 | 52.69 |
| Reserves & surplus | 39.18 | 36.68 | 24.96 | 16.97 |
| Total borrowing | — | — | 25.38 | 24.34 |
Figures in ₹ crore, as reported by the company in its offer document.
Objects of the issue
- 1.Part funding the capital expenditure towards setting up a new facility for manufacturing of sodium meta bisulphite, sodium bisulphite powder and ammonium bisulphite situated at Bavla, Ahmedabad, Gujarat;₹43 Cr
- 2.General Corporate Purposes—
What the company says it intends to do with the money raised.
Recent comparable IPOs
| Company | Issue price | P/E | Listing close | Listing gain |
|---|---|---|---|---|
| Devson Catalyst Ltd.SME | ₹118 | 9.66 | ₹205.95 | +74.53% |
| Vahh Chemicals Ltd.SME | ₹60 | 7.15 | ₹66.50 | +10.83% |
| Biopol Chemicals Ltd.SME | ₹108 | 19.73 | ₹105.50 | -2.31% |
| Neochem Bio Solutions Ltd.SME | ₹98 | 15.85 | ₹111.80 | +14.08% |
| Speb Adhesives Ltd.SME | ₹56 | 16.73 | ₹57.00 | +1.79% |
| SK Minerals & Additives Ltd.SME | ₹127 | 10.45 | ₹152.25 | +19.88% |
| Shlokka Dyes Ltd.SME | ₹91 | 13.69 | ₹85.50 | -6.04% |
| Sudeep Pharma Ltd.Mainboard | ₹593 | 47.61 | ₹774.15 | +30.55% |
Past listing performance of comparable issues. This is not a forecast: listing gains vary widely and can turn negative.
Issue fundamentals compiled from the company's offer document via Chittorgarh, last read 26 Aug 2026. Always verify against the RHP before applying.